1. Antimycobacterial and antileishmanial effects of microfungi isolated from tropical regions in México.
- Author
-
Gamboa-Angulo M, Molina-Salinas GM, Chan-Bacab M, Peraza-Sánchez SR, Heredia G, de la Rosa-García SC, and Reyes-Estebanez M
- Subjects
- Antiprotozoal Agents isolation & purification, Antitubercular Agents isolation & purification, Cell Survival drug effects, Humans, Inhibitory Concentration 50, Mexico, Microbial Sensitivity Tests, Tropical Climate, Antiprotozoal Agents pharmacology, Antitubercular Agents pharmacology, Fungi chemistry, Leishmania mexicana drug effects, Mycobacterium tuberculosis drug effects
- Abstract
A total of 82 fungal extracts were selected and screened against Mycobacterium tuberculosis and promastigotes of Leishmania mexicana strains. Results showed inhibitory activity in 29 % of the fungal strains against at least one of the targets tested. The most significant antituberculosis (antiTB) effects were presented by Cylindrocarpon sp. XH9B, Fusarium sp. TA54, Fusarium XH1Ga, Gliocladium penicillioides TH04 and TH21, Gliocladium sp. TH16, Kutilakesa sp. MR46, and Verticillium sp. TH28 strains (minimal inhibition concentration (MIC) = 1.56-25 μg/ml). Mortality of L. mexicana promastigotes was displayed by only four strains, Fusarium sp. TA50, Fusarium sp. TA54, Verticillium sp. TH28, and the unidentified 2TA2 strain (IC(50) = 14.23-100 μg/ml and IC(100) = 50-100 μg/ml). Seven of these most active strains were defatted and their corresponding fractions evaluated again. The results showed the best antiTB activity in Gliocladium sp. TH16 (MIC = 1.56 μg/ml) and the highest leishmanicidal potential in Fusarium sp. TA54 (IC(50) = 6.36 μg/ml). These results show that fungi living in the tropical regions of México have the ability to produce bioactive metabolites that could be used in the near future as natural products to control neglected tropical diseases.
- Published
- 2013
- Full Text
- View/download PDF